Correction of hypovitaminosis D does not improve the metabolic syndrome risk profile in a Chinese population: A randomized controlled trial for 1 year

Asia Pacific Journal of Clinical Nutrition

Volumn 25, Issue 1, 2016, Pages 71-77

  Yin, Xiao ^a   Yan, Ling ^a   Lu, Yong ^a   Jiang, Qiang ^a   Pu, Ying ^a   Sun, Qiang ^b  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Chinese; Metabolic syndrome; Obesity; Vitamin D deficiency; Vitamin D supplementation

Indexed keywords

25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; INSULIN; LIPID; PARATHYROID HORMONE; PLACEBO; VITAMIN D;

ADULT; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; BODY MASS; CHINA; COMPLICATION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VITAMIN D DEFICIENCY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PARATHYROID HORMONE; PLACEBOS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84966600200     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2016.25.1.06     Document Type: Article

References (36)

1. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008;47:87-91. doi: 10. 1007/s00394-008-0700-4
2. Boucher B. Vitamin D, obesity, and risk of diabetes. Lancet Diabetes Endocrinol. 2014;2:361-2. doi: 10.1016/S2213-85 87(14)70083-X
3. Schmitz KJ, Skinner HG, Bautista LE, Fingerlin TE, Langefeld CD, Hicks PJ et al. Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hypertens. 2009;22:867-70. doi: 10.1038/ajh.2009.88
4. Sypniewska G, Pollak J, Strozecki P, Camil F, Kretowicz M, Janikowski G, Mankowska-Cyl A, Pater A, Manitius J. 25-hydroxyvitamin D, biomarkers of endothelial dysfunction and subclinical organ damage in adults with hypertension. Am J Hypertens. 2014;27:114-21. doi: 10.1093/ajh/hpt174
5. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008;57:298-305. doi: 10.2337/db 07-1122
6. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009;32:1278-83. doi: 10.2337/dc09-0209
7. Ju SY, Jeong HS, Kim do H. Blood vitamin D status and metabolic syndrome in the general adult population: a doseresponse meta-analysis. J Clin Endocrinol Metab. 2014;99: 1053-63. doi: 10.1210/jc.2013-3577
8. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2009;59:242-8. doi: 10.2337/db09-1011
9. Lavie CJ, Dinicolantonio JJ, Milani RV, O'Keefe JH. Vitamin D and cardiovascular health. Circulation. 2013;128: 2404-6. doi: 10.1161/CIRCULATIONAHA.113.002902
10. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369:1991-2000. doi: 10.1056/NEJMoa1306357
11. Kant AK, Graubard BI. Race-ethnic, family income, and education differentials in nutritional and lipid biomarkers in US children and adolescents: NHANES 2003-2006. Am J Clin Nutr. 2012;96:601-12. doi: 10.3945/ajcn.112.035535
12. Armas LA, Dowell S, Akhter M, Duthuluru S, Huerter C, Hollis BW, Lund R, Heaney RP. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol. 2007;57: 588-93. doi: 10.1016/j.jaad.2007.03.004
13. Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA. 2013;310:179-88. doi: 10.1001/jama.2013.7228
14. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallelgroup, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab. 2012;97:3557-68. doi: 10.1210/jc.2012-2126
15. Didriksen A, Grimnes G, Hutchinson MS, Kjaergaard M, Svartberg J, Joakimsen RM, Jorde R. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol. 2013;169:559-67. doi: 10.1530/EJE-13-0233
16. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010;33:234-8. doi: 10.3275/6560
17. Yin X, Sun Q, Zhang X, Lu Y, Sun C, Cui Y, Wang S. Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutr J. 2012;11:68. doi: 10.1186/1475-2891-11-68
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52. doi: 10.1161/CIRCULATIONAHA.105.169404
19. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-8. doi: 10.1016/j.annepidem.2007.12.001
20. Zhang J, Wang HJ, Wang ZH, Zhang JG, Du WW, Su C, Zhai FY, Zhang B. Trend in dietary calcium intake among Chinese elderly aged 50 years and over in nine provinces, from 1991 to 2009. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;11:1119-22. (In Chinese)
21. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63. doi: 10.2337/diacare.23.1.57
22. Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-offpoints of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;11(Suppl):83-96S. doi: 10.1046/j. 1440-6047.11.s8.9.x
23. Ning G, Pan C, Fu Z, Chen B, Chen L, Chen M, Zhou D, Tong N. Management of obesity in adults: Chinese clinical practical guidelines. Chinese Journal of Endocrinology and Metabolism. 2011;27:711-17. doi: 10.1210/jcem.83.5.4774. (In Chinese)
24. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-8. doi: 10.1210/jc.2010-2704
25. Peterlik M. Vitamin D insufficiency and chronic diseases: hype and reality. Food Funct. 2012;3:784-94. doi: 10.1039/c2fo10262e
26. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92: 2017-29. doi: 10.1210/jc.2007-0298
27. Candido FG, Bressan J. Vitamin D: link between osteoporosis, obesity, and diabetes? Int J Mol Sci. 2014; 15:6569-91. doi: 10.3390/ijms15046569
28. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006; 29:650-6. doi: 10.2337/diacare.29.03.06.dc05-1961
29. Luo C, Wong J, Brown M, Hooper M, Molyneaux L, Yue DK. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diab Vasc Dis Res. 2009;6:194-9. doi: 10.1177/1479164109337974
30. Avenell A, Cook JA, MacLennan GS, McPherson GC. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2009;38: 606-9. doi: 10.1093/ageing/afp109
31. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30:980-6. doi: 10.2337/dc06-1994
32. Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr. 2007;85:54-9. doi: 10.3945/ajcn.2008.27004
33. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94:4023-30. doi: 10.1210/jc.2008-1212
34. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008;31:701-7. doi: 10.2337/dc07-1829
35. Tai K, Need AG, Horowitz M, Chapman IM. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition. 2008;24:950-6. doi: 10.1016/j.nut. 2008.04.009
36. Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012;60:870-4. doi: 10.1016/j.cyto.2012.07.032